Free Trial
CVE:KNE

Kane Biotech (KNE) Stock Price, News & Analysis

Kane Biotech logo
C$0.05 +0.01 (+11.11%)
As of 07/10/2025 09:40 AM Eastern

About Kane Biotech Stock (CVE:KNE)

Key Stats

Today's Range
C$0.05
C$0.05
50-Day Range
C$0.05
C$0.08
52-Week Range
C$0.05
C$0.16
Volume
1,000 shs
Average Volume
70,013 shs
Market Capitalization
C$7.20 million
P/E Ratio
1.25
Dividend Yield
3.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

KNE Stock News Headlines

Kane Biotech Provides Further Corporate Update
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Directors buying at Kane Biotech (KNE)
See More Headlines

KNE Stock Analysis - Frequently Asked Questions

Kane Biotech's stock was trading at C$0.11 at the start of the year. Since then, KNE stock has decreased by 54.5% and is now trading at C$0.05.

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kane Biotech investors own include Mason Resources (LLG), Datametrex AI (DM) and Allstar Health Brands (ALST).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:KNE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.04
Trailing P/E Ratio
1.25
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$6.03 million
Net Margins
423.52%
Pretax Margin
N/A
Return on Equity
-94.49%
Return on Assets
-58.43%

Debt

Debt-to-Equity Ratio
-331.42
Current Ratio
0.80
Quick Ratio
0.39

Sales & Book Value

Annual Sales
C$1.42 million
Price / Sales
5.06
Cash Flow
C$0.01 per share
Price / Cash Flow
8.50
Book Value
C($0.01) per share
Price / Book
-9.71

Miscellaneous

Outstanding Shares
144,060,190
Free Float
N/A
Market Cap
C$7.20 million
Optionable
Not Optionable
Beta
0.52
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (CVE:KNE) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners